Retaglutide is a novel GLP-1 receptor agonist currently under investigation for the control of type 2 diabetes. This drug works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring hormone https://janaaycq363733.blogitright.com/39278601/retaglutide-a-promising-glp-1-receptor-agonist